1. Home
  2. CLLS vs SIFY Comparison

CLLS vs SIFY Comparison

Compare CLLS & SIFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • SIFY
  • Stock Information
  • Founded
  • CLLS 1999
  • SIFY 1995
  • Country
  • CLLS France
  • SIFY India
  • Employees
  • CLLS 216
  • SIFY N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • SIFY Computer Software: Programming Data Processing
  • Sector
  • CLLS Health Care
  • SIFY Technology
  • Exchange
  • CLLS Nasdaq
  • SIFY Nasdaq
  • Market Cap
  • CLLS 148.1M
  • SIFY 218.1M
  • IPO Year
  • CLLS 2007
  • SIFY 1999
  • Fundamental
  • Price
  • CLLS $1.48
  • SIFY $2.89
  • Analyst Decision
  • CLLS Buy
  • SIFY
  • Analyst Count
  • CLLS 3
  • SIFY 0
  • Target Price
  • CLLS $7.00
  • SIFY N/A
  • AVG Volume (30 Days)
  • CLLS 235.1K
  • SIFY 77.5K
  • Earning Date
  • CLLS 11-04-2024
  • SIFY 01-17-2025
  • Dividend Yield
  • CLLS N/A
  • SIFY N/A
  • EPS Growth
  • CLLS N/A
  • SIFY N/A
  • EPS
  • CLLS N/A
  • SIFY N/A
  • Revenue
  • CLLS $36,042,000.00
  • SIFY $465,333,571.00
  • Revenue This Year
  • CLLS $387.77
  • SIFY N/A
  • Revenue Next Year
  • CLLS $11.14
  • SIFY $12.52
  • P/E Ratio
  • CLLS N/A
  • SIFY N/A
  • Revenue Growth
  • CLLS 46.96
  • SIFY 14.34
  • 52 Week Low
  • CLLS $1.41
  • SIFY $1.80
  • 52 Week High
  • CLLS $3.38
  • SIFY $10.14
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 38.66
  • SIFY 44.10
  • Support Level
  • CLLS $1.65
  • SIFY $2.81
  • Resistance Level
  • CLLS $2.23
  • SIFY $3.29
  • Average True Range (ATR)
  • CLLS 0.18
  • SIFY 0.19
  • MACD
  • CLLS -0.03
  • SIFY 0.01
  • Stochastic Oscillator
  • CLLS 8.54
  • SIFY 16.67

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.

About SIFY Sify Technologies Limited

Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.

Share on Social Networks: